维普期刊资源整合服务平台（V6.5）

29篇 您的检索式：作者名="Shimohata M"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Clinical features of pa-tients with myasthenia gravis associated with autoimmune diseases 显示文摘	Kallazawa M Shimohata T Tanaka K	2007	Eur J Neurol2007，14，：	1
2	Widespread occurrence of intranuclear atrophin-1 accumulation in the central nervous system neurons of patients with dentatorubral-pallidoluysian atrophy显示文摘	Yamada M Wood JD Shimohata T	2001	Ann Neurol2001，49，1：	1
3	Clinical features of patients' with myasthenia gravis associated with autoimmune dis- eases显示文摘	Kanazawa M Shimohata T Tanaka K	2007	Eur J Neurol2007，14，12：	1
4	Interference of CREB-dependent transcriptional activation by expanded polyglutamine stretches--augmentation of transcriptional activation as a potential therapeutic strategy for polyglutamine diseases显示文摘	Shimohata M Shimohata T Igarashi S	2005	J Neurochem2005，93，3：	1
5	Cerebellar involvement in progressive supranuclear palsy: A clinicopathological study显示文摘	Kanazawa M Shimohata T Toyoshima Y	2009	Mov Disord2009，24，9：	1
6	Interaction between neuronal intranuclear inclusions and promyelocytic leukemia protein nuclear and coiled bodies in CAG repeat diseases显示文摘	YAMADA M SATO T SHIMOHATA T	2001	The American Journal of Pathology2001，159，5：	1
7	Cerebellar involvement in progressive suprartuclear palsy: a clinico- pathological study 显示文摘	Kanagawa M Shimohata T Toyoshima Y	2009	Mov Disord2009，，9：	1
8	Long-term therapeutic efficacy and safety of low-dose tacrolimus (FKS06) for myasthenia gravis显示文摘	Tada M Shimohata T Tada M	2006	J Neurol Sci2006，247，1：	1
9	Clinical features of patients with myasthenia gravis associated with autoimmune diseases显示文摘	Kanazawa M shimohata T Tanaka K	2007	Eur J Neurol2007，14，12：	1
10	Long-term therapeu- tic efficacy and safety of low-dose tacrolimus (FKS06) for myasthenia gravis显示文摘	Tada M Shimohata T Tada M	2006	J Neurol Sci2006，247，1：	1
11	Clinical features of multiple system atrophy显示文摘	Nishizawa M Shimohata T	2009	Rinsho Shinkeigaku2009，49，5：	1
12	Disease notification and self-determination in treatment decisions for patients with Creu- tzfe\|dt-J akobdisease显示文摘	Yanagimura F Shimohata T Tada M	2014	Clin Neurol2014，54，4：	1
13	Clinical features of patients with myasthenia gravis associated with autoimmune disease 显示文摘	Kanazawa M Shimohata T Tanaka K	2007	Eur J Neurol2007，14，2：	1
14	Cere- bellar involvement in progressive supranuclear palsy: A clinicopathological study 显示文摘	Kanazawa M Shimohata T Toyoshima Y	2009	Mov Disord2009，24，9：	1
15	Clinical fea- tures of patients with myasthenia gravis associated with auto- immune diseases显示文摘	Kanazawa M Shimohata T Tanaka K	2007	Eur J Neurol2007，14，：	1
16	Cerebellar involvement in progressive supranuclear palsy: a clinicopathological study 显示文摘	Kanazawa M Shimohata T Toyoshima Y	2009	Mov Disord2009，24，：	1
17	Clinical features ofpatients with myasthenia gravis associated with autoimmune dis-eases显示文摘	Kanazawa M Shimohata T Tanaka K	2007	European Journal Of Neurology2007，14，12：	1
18	Long-term Therapeutic Efficacy and Safety of Low-dose Tacrolimus (FK506)for Myasthenia Gravis显示文摘	TADA M sHIMOHATA T TADA M	2006	J Neurol Sci(S0022-510X)2006，247，1：	1
19	Five year followup of a patient with spinal and bulbar muscular atrophy trea-ted with leuprorelin 显示文摘	Shimohata T Kimura T Nishizawa M	2004	Jouranl of Neurology Neurosurgeryand Psychiatry2004，75，8：	1
20	Spinocerebellarataxia type 2 ( SCA2) is associated with TDP-43 pathology 显示文摘	Toyoshima Y Tanaka H Shimohata M	2011	Acta Neuropathol2011，122，：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示